Given the role of RAGE activation in the development of insulin resistance, it is conceivable that silencing the signals transmitted by this receptor may represent a therapeutic strategy to improve insulin sensitivity in patients with impaired glucose tolerance. This evidence concerns the gene AGER and Impaired glucose tolerance.